Word

GALAPAGOS

Status

Registered

Status Code

700

Status Date

Tuesday, October 22, 2019

Serial Number

88110392

Registration Number

5888518

Registration Date

Tuesday, October 22, 2019

Mark Type

4000

Filing Date

Monday, September 10, 2018

Published for Opposition

Tuesday, August 6, 2019

Trademark Owner History

Galapagos N.V. - Original Registrant

Classifications

5 pharmaceutical substances and preparations for human use, namely, for the treatment of bone cartilage and joint disease, autoinflammation diseases, autoimmune diseases, proliferative diseases, endocrine diseases, metabolic diseases, skin diseases, lung diseases, fibrotic diseases, cardiovascular diseases, pain, hepatitis B virus, kidney diseases, osteoporosis, osteoarthritis, rheumatoid arthritis, atopic dermatitis, idiopathic pulmonary fibrosis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, lupus, uveitis, scleroderma, non-alcoholic steatohepatitis, polycystic kidney disease, type 2 diabetes; biopharmaceutical substances and preparations for human use, namely, for the treatment of bone cartilage and joint disease, autoinflammation diseases, autoimmune diseases, proliferative diseases, endocrine diseases, metabolic diseases, skin diseases, lung diseases, fibrotic diseases, cardiovascular diseases, pain, hepatitis B virus, kidney diseases, osteoporosis, osteoarthritis, rheumatoid arthritis, atopic dermatitis, idiopathic pulmonary fibrosis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, lupus, uveitis, scleroderma, non-alcoholic steatohepatitis, polycystic kidney disease, type 2 diabetes

44 medical services; medical and pharmaceutical advisory and consultancy services; gene bank services

42 medical and scientific research services; industrial research services in the field of assay development, target discovery and validation, drug development, and medicinal chemistry; pharmaceutical and biopharmaceutical research and development services; medical and scientific research, namely, the examination and testing of genes; development, laboratory analysis, and testing of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; development, laboratory analysis, and testing of medicaments; the development of clinical assays, cellular tests, testing kits, diagnostic kits, and companion diagnostics for evaluating pharmaceutical and biopharmaceutical products of others; development of computer databases in the medical, pharmaceutical and biopharmaceutical fields and gathering of data to populate same via collection of medical, pharmaceutical, biopharmaceutical research and clinical trial data; and gene bank services for research purposes

Trademark Events

Oct 22, 2019

Registered-Principal Register

Aug 6, 2019

Official Gazette Publication Confirmation E-Mailed

Aug 6, 2019

Published For Opposition

Jul 17, 2019

Notification Of Notice Of Publication E-Mailed

Jul 2, 2019

Electronic Record Review Complete

Jun 28, 2019

On Hold - Electronic Record Review Required

Jun 24, 2019

Approved For Pub - Principal Register

Jun 10, 2019

Teas/Email Correspondence Entered

Jun 10, 2019

Correspondence Received In Law Office

Jun 5, 2019

Teas Voluntary Amendment Received

May 27, 2019

Teas/Email Correspondence Entered

May 27, 2019

Correspondence Received In Law Office

May 27, 2019

Teas Response To Office Action Received

Jan 8, 2019

Notification Of Non-Final Action E-Mailed

Jan 8, 2019

Non-Final Action E-Mailed

Jan 8, 2019

Non-Final Action Written

Dec 19, 2018

Assigned To Examiner

Oct 22, 2018

Preliminary/Voluntary Amendment - Entered

Oct 18, 2018

Assigned To Lie

Oct 9, 2018

Teas Voluntary Amendment Received

Sep 17, 2018

New Application Office Supplied Data Entered

Sep 13, 2018

New Application Entered